Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era.
Department of Medicine and Biosystemic Science, School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yasuo
Y
Mori
Toshihiro
T
Miyamoto
Kenjiro
K
Kamezaki
Koji
K
Kato
Yoshikane
Y
Kikushige
Shuichiro
S
Takashima
Shingo
S
Urata
Shinji
S
Shimoda
Nobuyuki
N
Shimono
Katsuto
K
Takenaka
Hiromi
H
Iwasaki
Koji
K
Nagafuji
Takanori
T
Teshima
Koichi
K
Akashi
D000257:Adenoviridae Infections / Q000453:epidemiology* / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003556:Cystitis / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab; D014182:Transplantation, Autologous
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab